tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

RHHBY Stock Latest News

Sarepta announces commercial launch of Elevidys in Japan
The FlySarepta announces commercial launch of Elevidys in Japan
2d ago
CHRO
SRPT
VYMI vs. VIGI vs. VPU: Which Vanguard Dividend ETF Is Best for Steady Passive Income?
PremiumMarket News
VYMI vs. VIGI vs. VPU: Which Vanguard Dividend ETF Is Best for Steady Passive Income?
6d ago
SO
NEE
Roche announces U.S. FDA accepted NDA for giredestrant with everolimus
PremiumThe Fly
Roche announces U.S. FDA accepted NDA for giredestrant with everolimus
6d ago
CHRO
Genentech gets FDA acceptance for giredestrant combination new drug application
PremiumThe Fly
Genentech gets FDA acceptance for giredestrant combination new drug application
6d ago
CHRO
Genentech gets FDA approval for venclexta, acalabrutinib combination regimen
PremiumThe Fly
Genentech gets FDA approval for venclexta, acalabrutinib combination regimen
6d ago
CHRO
Roche price target raised to CHF 340 from CHF 320 at Berenberg
PremiumThe FlyRoche price target raised to CHF 340 from CHF 320 at Berenberg
7d ago
CHRO
Roche management to meet virtually with Piper Sandler
Premium
The Fly
Roche management to meet virtually with Piper Sandler
7d ago
CHRO
FDA to begin requiring on clinical trial
Premium
The Fly
FDA to begin requiring on clinical trial
8d ago
AZN
BMY
FDA to begin requiring one clinical trial in drug approvals
PremiumThe Fly
FDA to begin requiring one clinical trial in drug approvals
8d ago
AZN
BMY
Roche reports MAJESTY study met primary endpoint
PremiumThe Fly
Roche reports MAJESTY study met primary endpoint
10d ago
CHRO
Roche’s New Breast Cancer Trial Pits Its Pipeline Against Eli Lilly’s Standard: What It Means for RHHBY
PremiumCompany Announcements
Roche’s New Breast Cancer Trial Pits Its Pipeline Against Eli Lilly’s Standard: What It Means for RHHBY
13d ago
RHHBY
Why Is Immunic Stock (IMUX) Up 27% Today?
PremiumMarket News
Why Is Immunic Stock (IMUX) Up 27% Today?
13d ago
IMUX
Roche price target raised to $67 from $60 at TD Cowen
PremiumThe FlyRoche price target raised to $67 from $60 at TD Cowen
16d ago
CHRO
VIG vs. VYM vs. VYMI: Which Is Vanguard’s Best Dividend ETF for Reliable Passive Income?
Premium
Market News
VIG vs. VYM vs. VYMI: Which Is Vanguard’s Best Dividend ETF for Reliable Passive Income?
17d ago
NVS
VIG
Roche’s Genentech announces fenebrutinib met its primary endpoint
Premium
The Fly
Roche’s Genentech announces fenebrutinib met its primary endpoint
18d ago
CHRO
Trump Trade: Argentina says U.S. to cut hundreds of tariffs
PremiumThe Fly
Trump Trade: Argentina says U.S. to cut hundreds of tariffs
20d ago
BA
AZN
TrumpRx website using technology from GoodRx, STAT says
PremiumThe Fly
TrumpRx website using technology from GoodRx, STAT says
21d ago
AZN
BMY
Roche price target raised to CHF 295 from CHF 290 at Morgan Stanley
PremiumThe Fly
Roche price target raised to CHF 295 from CHF 290 at Morgan Stanley
22d ago
CHRO
Roche Earnings Call: Strong Growth, Deep Pipeline Momentum
PremiumCompany Announcements
Roche Earnings Call: Strong Growth, Deep Pipeline Momentum
27d ago
Roche reports FY25 group sales CHF 61.52B vs. CHF 60.5B last year
PremiumThe FlyRoche reports FY25 group sales CHF 61.52B vs. CHF 60.5B last year
28d ago
CHRO
Roche board proposes dividend increase to CHF 9.80 per share
Premium
The Fly
Roche board proposes dividend increase to CHF 9.80 per share
28d ago
CHRO
Roche expects increase in group sales in mid single digit range for FY26
Premium
The Fly
Roche expects increase in group sales in mid single digit range for FY26
28d ago
CHRO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >